Those patients, who had ERα-positive breast tumors with low expression of Nrf2, ABCC1, ABCC3 and NQO1 at the time diagnosis, had a better prognosis after tamoxifen treatment than those patients that were high expressers, with an HR value as high as 4.2. Here, ESR1 is linked to breast neoplasm.